Journal article icon

Journal article

Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis

Abstract:
Background Tamoxifen was recommended by NICE in 2013 for chemoprevention of breast cancer, but a recent survey suggested only a quarter of GPs are aware of this. We set out to measure the uptake of tamoxifen, and the alternative raloxifene, in national prescribing data sets. Methods Tamoxifen and raloxifene data were extracted from England’s monthly prescribing data sets, October 2010–October 2017. We used interrupted time series analysis to reveal national ... Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1038/s41416-018-0065-2

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Primary Care Health Sciences
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Primary Care Health Sciences
ORCID:
0000-0003-4932-6135
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Primary Care Health Sciences
More from this funder
Funding agency for:
Goldacre, B
Publisher:
Springer Nature Publisher's website
Journal:
British Journal of Cancer Journal website
Volume:
118
Pages:
1268–1275
Publication date:
2018-04-23
Acceptance date:
2018-03-05
DOI:
EISSN:
1532-1827
ISSN:
0007-0920
Pubs id:
pubs:844821
URN:
uri:f688c155-5966-41c2-b187-b7293374ebc1
UUID:
uuid:f688c155-5966-41c2-b187-b7293374ebc1
Local pid:
pubs:844821
Language:
English

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP